istatud
Istatud is a medication primarily used to treat human immunodeficiency virus (HIV) infection. It is an integrase strand transfer inhibitor (INSTI), a class of antiretroviral drugs that prevent the integration of viral DNA into the host's genome.
The active ingredient in istatud is an atacicept derivative. It functions by blocking the integrase enzyme,
Istatud was approved for use in several countries in the 2020s. It is often prescribed in combination
The safety profile of istatud has been extensively studied. Common side effects reported by patients treated
The benefit-risk profile of istatud is considered favorable by regulatory authorities and the medical community. As